# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k113438   
B. Purpose for Submission: New Device   
C. Measurand: Total iron-binding capacity Iron Lipase   
D. Type of Test: Quantitative, colorimetric assay   
E. Applicant: Alfa Wassermann Diagnostic Technologies, LLC

F. Proprietary and Established Names: ACE Direct Total Iron-Binding capacity (TIBC) Reagent ACE Serum Iron Reagent ACE Lipase Reagent

# G. Regulatory Information:

<table><tr><td rowspan=1 colspan=1>Product Code</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>JMO</td><td rowspan=1 colspan=1>Class I, reserved</td><td rowspan=1 colspan=1>21 C.F.R. §862.1415Iron-Binding CapacityTest</td><td rowspan=1 colspan=1>Clinical Chemistry(75)</td></tr><tr><td rowspan=1 colspan=1>JIY</td><td rowspan=1 colspan=1>Class I, reserved</td><td rowspan=1 colspan=1>21 C.F.R. §862.1410Iron (non-heme) TestSystem</td><td rowspan=1 colspan=1>Clinical Chemistry(75)</td></tr><tr><td rowspan=1 colspan=1>CHI</td><td rowspan=1 colspan=1>Class I (meets thelimitations ofexemptions in 21CFR 862.9(c)(9)</td><td rowspan=1 colspan=1>21 C.F.R.§ 862.1465Lipase Test System</td><td rowspan=1 colspan=1>Clinical Chemistry(75)</td></tr></table>

# H. Intended Use:

1. Intended use(s): Please see indication use below.

2. Indication(s) for use:

ACE TIBC Reagent is intended for the quantitative determination of total iron-binding capacity in serum using the ACE Axcel Clinical Chemistry System. Iron-binding capacity measurements are used in the diagnosis and treatment of anemia. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.

The ACE Serum Iron Reagent is intended for the quantitative determination of iron concentration in serum using the ACE Axcel Clinical Chemistry System. Iron (nonheme) measurements are used in the diagnosis and treatment of diseases such as iron deficiency anemia, hemochromatosis (a disease associated with widespread deposit in the tissues of two iron-containing pigments, hemosiderin and hemofusion, and characterized by pigmentation of the skin), and chronic renal disease. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.

The ACE Lipase Reagent is intended for the quantitative determination of lipase activity in serum using the ACE Axcel Clinical Chemistry System. Lipase measurements are used in diagnosis and treatment of diseases of the pancreas such as acute pancreatitis and obstruction of the pancreatic duct. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.

3. Special conditions for use statement(s): For prescription Use.

4. Special instrument requirements: ACE Axcel Clinical Chemistry System

# I. Device Description:

ACE Direct Total Iron-Binding capacity (TIBC) Reagent assay consists of the Direct TIBC Color Reagent (R1) and the Direct TIBC Buffer (R2). The Direct TIBC Color Reagent contains chromazurol B, cetrimide, ferric chloride and acetate buffer. The Direct TIBC Buffer contains sodium bicarbonate buffer. Both reagents are added to the serum sample.

ACE Serum Iron Reagent is composed of two reagent bottles, Buffer (R1) and Color Reagent (R2). The Buffer contains hydroxylamine hydrochloride, acetate buffer $\left( \mathsf { p H 4 . 5 } \right)$ and surfactant. The Color Reagent contains ferrozine and hydroxylamine hydrochloride.

ACE Lipase Reagent is composed of two reagents, the Lipase Reagent (R1) and the Lipase Activator Reagent (R2). The Lipase Reagent contains 1, 2dycliceride, monoglyceride lipase, glycerol kinase, glycerol-3-phosphate oxidase, N-ethyl-N-(2-hydroxy-3-sulfopropyl)-m

toluidine, ATP, peroxidase and cholic acid. The Lipase Activator Reagent contains deoxycholate and 4-Aminoantipyrene.

# J. Substantial Equivalence Information:

1. Predicate device name(s): ACE Clinical Chemistry System, ACE TIBC Reagent ACE Clinical Chemistry System, ACE Serum Iron Reagent ACE Clinical Chemistry System, ACE Lipase Reagent

2. Predicate 510(k) number(s): k931786

3. Comparison with predicate:

<table><tr><td rowspan=1 colspan=1>Attribute</td><td rowspan=1 colspan=1>ACE Direct Total Iron-BindingCapacity (TIBC) Reagent(Candidate Device  k113438)</td><td rowspan=1 colspan=1>ACE Clinical ChemistrySystem, ACE TIBC Reagent(Predicate  k931786)</td></tr><tr><td rowspan=1 colspan=1>Indication for use /Intended Use</td><td rowspan=1 colspan=1>It is intended for the quantitativedetermination of Total Iron BindingCapacity in serum</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Instrument</td><td rowspan=1 colspan=1>ACE Axcel Clinical ChemistrySystem</td><td rowspan=1 colspan=1>ACE and ACE Alera®Clinical Chemistry Systems</td></tr><tr><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reagent type</td><td rowspan=1 colspan=1>Two part liquid</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>ReactionType/TestMethodology</td><td rowspan=1 colspan=1>Delta/ Measurement of the capacity ofserum protein to bind to iron using adye.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Measuring range</td><td rowspan=1 colspan=1>42 - 700 μg/dL</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>StorageTemperature afteropening</td><td rowspan=1 colspan=1>10-14°C for 8 hrs per day / capped andrefrigerated at 2-8 °C when not in use</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Onboard StabilityClaim</td><td rowspan=1 colspan=1>30 days</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Shelf life</td><td rowspan=1 colspan=1>Stable until expiration date on boxwhen stored at 2-8°C</td><td rowspan=1 colspan=1>Same</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Attribute</td><td colspan="1" rowspan="1">ACE Serum Iron Reagent(Candidate Device  k113438)</td><td colspan="1" rowspan="1">ACE Clinical ChemistrySystem, ACE Serum IronReagent(Predicate  k931786)</td></tr><tr><td colspan="1" rowspan="1">Indication for use /Intended Use</td><td colspan="1" rowspan="1">It is intended for the (quantitativedetermination of Iron in serum</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">ACE Axcel Clinical ChemistrySystem</td><td colspan="1" rowspan="1">ACE and ACE Alera' andNExCT Clinical ChemistrySystems</td></tr><tr><td colspan="1" rowspan="1">Sample</td><td colspan="1" rowspan="1">serum</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Reagent type</td><td colspan="1" rowspan="1">Two part liquid</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">ReactionType/TestMethodology</td><td colspan="1" rowspan="1">Endpoint/Ferrachrome/Ferrozinewithout protein removal</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Linearity range</td><td colspan="1" rowspan="1">12 - 600μg/dL</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">StorageTemperature afteropening</td><td colspan="1" rowspan="1">10-14°C</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Onboard StabilityClaim</td><td colspan="1" rowspan="1">30 days</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Shelf life</td><td colspan="1" rowspan="1">Stable until expiration date on boxwhen stored at 2-8°C</td><td colspan="1" rowspan="1">Same</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Attribute</td><td rowspan=1 colspan=1>ACE Lipase Reagent(Candidate Device  k113438)</td><td rowspan=1 colspan=1>ACE Clinical ChemistrySystem, ACE LipaseReagent(Predicate - k931786)</td></tr><tr><td rowspan=1 colspan=1>Indication for use /Intended Use</td><td rowspan=1 colspan=1>The ACE Lipase Reagent is intendedfor the quantitative determination oflipase activity in serum</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Instrument</td><td rowspan=1 colspan=1>ACE Axcel Clinical ChemistrySystem</td><td rowspan=1 colspan=1>ACE and ACE Alera®Clinical Chemistry Systems</td></tr><tr><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Serum</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Reagent type</td><td rowspan=1 colspan=1>Two part liquid</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>ReactionType/TestMethodology</td><td rowspan=1 colspan=1>Delta / Colorimetric method</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Linearity range</td><td rowspan=1 colspan=1>15- 700U/L</td><td rowspan=1 colspan=1>11 - 700U/L</td></tr><tr><td rowspan=1 colspan=1>StorageTemperature afteropening (onboard)</td><td rowspan=1 colspan=1>10-14°C</td><td rowspan=1 colspan=1>1 week @ 25°C3 weeks @ 2-8°C</td></tr><tr><td rowspan=1 colspan=1>Onboard StabilityClaim</td><td rowspan=1 colspan=1>20 days</td><td rowspan=1 colspan=1>20 days</td></tr><tr><td rowspan=1 colspan=1>Shelf life</td><td rowspan=1 colspan=1>Stable until expiration date on boxwhen stored at 2-8°C</td><td rowspan=1 colspan=1>Same</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline (CLSI EP6-A)

Interference Testing in Clinical Chemistry; Approved Guidelines- Second edition (CLSI EP7-A2)

Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline- Second Edition (CLSI EP5-A2)

Preliminary Evaluation of Quantitative Clinical Laboratory Measurement Procedures – Third Edition (CLSI EP10 –A3)

Method Comparison and Bias Estimation Using Patient Samples; Approved GuidelineSecond Edition (CLSI EP9-A2-IR)

Protocols for Determination of Limits of Detection; Approved Guideline (CLSI EP17-A)

# L. Test Principle:

ACE Direct Total Iron-Binding capacity (TIBC) Reagent

The Direct TIBC Color reagent releases iron from transferrin, forming a color complex with the dye. Then the Direct TIBC Buffer is added, shifting the pH and resulting in a large affinity of transferrin for iron. The serum transferrin rapidly binds the iron by abstracting the iron from the dye-iron complex. The decrease in absorbance is directly proportional to the total iron binding capacity of the serum sample. The absorbance is measured at $6 4 7 \mathrm { n m }$ .

# ACE Serum Iron Reagent

The transferring-bound iron in serum is released at a pH and reduced from ferric to ferrous iron. These ions react with ferrozine to form a violet color complex, which is measured bichromatically at $5 5 4 ~ \mathrm { n m } / 6 9 2 ~ \mathrm { n m }$ . The intensity of color produced is directly proportional to the serum iron concentration.

# ACE Lipase Reagent

Serum lipase acts on a natural substrate, 1, 2-diglyceride, to liberate 2-monoglyceride. A series of redox reactions take place leading to the formation of a quinine dye. The rate of formation of the dye, determined bichromatically at an absorbance of $5 7 3 \mathrm { n m } / 6 9 2 \mathrm { n m }$ , is proportional to the lipase activity in the sample.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

In house: ACE Direct Total Iron-Binding capacity (TIBC) Reagent

Within-Run and Total precision evaluations were determined following CLSI EP5- A2. Four levels, three serum based pool and one normal human serum sample, were tested on the ACE Axcel Clinical Chemistry System analyzer in two runs per day, with two replicates of each level per run for 22 days.

<table><tr><td rowspan=1 colspan=1>Sample 1Mean 176.3 µg/dL TIBC</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation,μg/dL</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>4.1</td><td rowspan=1 colspan=1>5.9</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>2.2%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>2.3%</td><td rowspan=1 colspan=1>3.3%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Sample 2Mean 342.8 μg/dLTIBC</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation,μg/dL</td><td rowspan=1 colspan=1>3.5</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>5.2</td><td rowspan=1 colspan=1>6.8</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>0.7%</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>2.0%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Sample 3Mean 444.9 μg/dLTIBC</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation,μg/dL</td><td rowspan=1 colspan=1>7.4</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>7.4</td><td rowspan=1 colspan=1>10.5</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>1.7%</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>1.7%</td><td rowspan=1 colspan=1>2.4%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Sample 4Mean 320.3 μg/dLTIBC</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>StandardDeviation,μg/dL</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>4.5</td><td rowspan=1 colspan=1>6.7</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.4%</td><td rowspan=1 colspan=1>2.1%</td></tr></table>

Point of Care Laboratory: ACE Direct Total Iron-Binding capacity (TIBC) Reagent Point of care precision evaluations were determined following CLSI EP10-A3. Three serum based pools were tested on the ACE Axcel Clinical Chemistry System analyzer in one run per day, with three replicates of each level per run for 5 days.

<table><tr><td rowspan=1 colspan=3>TIBC</td><td rowspan=1 colspan=2>Within Run</td><td rowspan=1 colspan=2>Total</td></tr><tr><td rowspan=1 colspan=1>Lab</td><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Meanμg/dL</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>POL 1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>177.3</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>1.8</td></tr><tr><td rowspan=1 colspan=1>POL 2</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>175.2</td><td rowspan=1 colspan=1>5.6</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>6.7</td><td rowspan=1 colspan=1>3.8</td></tr><tr><td rowspan=1 colspan=1>POL 3</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>180.1</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>3.4</td><td rowspan=1 colspan=1>7.4</td><td rowspan=1 colspan=1>4.1</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>POL 1</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>340.2</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>0.9</td></tr><tr><td rowspan=1 colspan=1>POL 2</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>334.2</td><td rowspan=1 colspan=1>4.1</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>9.7</td><td rowspan=1 colspan=1>2.9</td></tr><tr><td rowspan=1 colspan=1>POL 3</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>338.6</td><td rowspan=1 colspan=1>3.3</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>9.2</td><td rowspan=1 colspan=1>2.7</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>POL 1</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>439.7</td><td rowspan=1 colspan=1>6.9</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>8.2</td><td rowspan=1 colspan=1>1.9</td></tr><tr><td rowspan=1 colspan=1>POL 2</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>422.9</td><td rowspan=1 colspan=1>6.7</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>11.6</td><td rowspan=1 colspan=1>2.8</td></tr><tr><td rowspan=1 colspan=1>POL 3</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>433.6</td><td rowspan=1 colspan=1>8.9</td><td rowspan=1 colspan=1>2.1</td><td rowspan=1 colspan=1>12.0</td><td rowspan=1 colspan=1>2.8</td></tr></table>

# In house: ACE Serum Iron Reagent

Within-Run and Total precision evaluations were determined following CLSI EP5- A2. Four levels, three serum based pool and one normal human serum sample were tested on one ACE Axcel Clinical Chemistry System analyzer in two runs per day, with two replicates of each level per run for 22 days.

<table><tr><td rowspan=1 colspan=1>Sample 1Mean 70.2 μg/dLTotal Iron</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation, μg/dL</td><td rowspan=1 colspan=1>3.7</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>3.8</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>5.2%</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>5.4%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Sample 2Mean 269.6 μg/dLTotal Iron</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation, μg/dL</td><td rowspan=1 colspan=1>6.3</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>6.5</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>2.3%</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>2.4%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Sample 3Mean 457.1 μg/dLTotal Iron</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation, µg/dL</td><td rowspan=1 colspan=1>5.5</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>6.1</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>0.6%</td><td rowspan=1 colspan=1>1.2%</td><td rowspan=1 colspan=1>1.3%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Sample 4Mean 58.8 μg/dLTotal Iron</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation, μg/dL</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>0.0</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>3.1</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>4.7%</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>2.5%</td><td rowspan=1 colspan=1>5.3%</td></tr></table>

# Point of Care Laboratory: ACE Serum Iron Reagent

Point of care precision evaluations were determined following CLSI EP10-A3. Three serum based pools were tested on the ACE Axcel Clinical Chemistry System analyzer in one run per day, with three replicates of each level per run for 5 days.

<table><tr><td colspan="3" rowspan="1">Total Iron</td><td colspan="2" rowspan="1">Within Run</td><td colspan="2" rowspan="1">Total</td></tr><tr><td colspan="1" rowspan="1">Lab</td><td colspan="1" rowspan="1">Sample</td><td colspan="1" rowspan="1">Meanμg/dL</td><td colspan="1" rowspan="1">SD</td><td colspan="1" rowspan="1">%CV</td><td colspan="1" rowspan="1">SD</td><td colspan="1" rowspan="1">%CV</td></tr><tr><td colspan="1" rowspan="1">POL 1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">71.3</td><td colspan="1" rowspan="1">2.9</td><td colspan="1" rowspan="1">4.1</td><td colspan="1" rowspan="1">2.9</td><td colspan="1" rowspan="1">4.1</td></tr><tr><td colspan="1" rowspan="1">POL 2</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">72.5</td><td colspan="1" rowspan="1">2.5</td><td colspan="1" rowspan="1">3.4</td><td colspan="1" rowspan="1">2.6</td><td colspan="1" rowspan="1">3.6</td></tr><tr><td colspan="1" rowspan="1">POL 3</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">79.5</td><td colspan="1" rowspan="1">2.1</td><td colspan="1" rowspan="1">2.6</td><td colspan="1" rowspan="1">3.3</td><td colspan="1" rowspan="1">4.2</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">POL 1</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">269.2</td><td colspan="1" rowspan="1">4.4</td><td colspan="1" rowspan="1">1.6</td><td colspan="1" rowspan="1">4.4</td><td colspan="1" rowspan="1">1.6</td></tr><tr><td colspan="1" rowspan="1">POL 2</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">272.5</td><td colspan="1" rowspan="1">4.2</td><td colspan="1" rowspan="1">1.5</td><td colspan="1" rowspan="1">4.2</td><td colspan="1" rowspan="1">1.5</td></tr><tr><td colspan="1" rowspan="1">POL 3</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">281.7</td><td colspan="1" rowspan="1">3.9</td><td colspan="1" rowspan="1">1.4</td><td colspan="1" rowspan="1">4.7</td><td colspan="1" rowspan="1">1.7</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">POL 1</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">457.0</td><td colspan="1" rowspan="1">5.6</td><td colspan="1" rowspan="1">1.2</td><td colspan="1" rowspan="1">5.6</td><td colspan="1" rowspan="1">1.2</td></tr><tr><td colspan="1" rowspan="1">POL 2</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">458.8</td><td colspan="1" rowspan="1">7.8</td><td colspan="1" rowspan="1">1.7</td><td colspan="1" rowspan="1">7.8</td><td colspan="1" rowspan="1">1.7</td></tr><tr><td colspan="1" rowspan="1">POL 3</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">473.3</td><td colspan="1" rowspan="1">6.3</td><td colspan="1" rowspan="1">1.3</td><td colspan="1" rowspan="1">6.3</td><td colspan="1" rowspan="1">1.3</td></tr></table>

# In house: ACE Lipase Reagent

Within-Run and Total precision evaluations were determined following CLSI EP5- A2. Four serum based levels of lipase were tested on the ACE Axcel Clinical Chemistry System analyzer in two runs per day with two replicates of each level per run for 22 days.

<table><tr><td rowspan=1 colspan=1>Sample 1Mean 38.5 U/L Lipase</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation, U/L</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>2.8</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>4.1</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>6.5%</td><td rowspan=1 colspan=1>7.3%</td><td rowspan=1 colspan=1>4.4%</td><td rowspan=1 colspan=1>10.7%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Sample 2Mean 248.35 U/L Lipase</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation,U/L</td><td rowspan=1 colspan=1>3.62</td><td rowspan=1 colspan=1>2.53</td><td rowspan=1 colspan=1>15.13</td><td rowspan=1 colspan=1>15.76</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>1.5%</td><td rowspan=1 colspan=1>1.0%</td><td rowspan=1 colspan=1>6.1%</td><td rowspan=1 colspan=1>6.3%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Sample 3Mean 403.27 U/L Lipase</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation,,U/L</td><td rowspan=1 colspan=1>4.61</td><td rowspan=1 colspan=1>3.53</td><td rowspan=1 colspan=1>24.40</td><td rowspan=1 colspan=1>25.08</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>1.1%</td><td rowspan=1 colspan=1>0.9%</td><td rowspan=1 colspan=1>6.1%</td><td rowspan=1 colspan=1>6.2%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Sample 4Mean 56.0 U/L Lipase</td><td rowspan=1 colspan=1>WithinRun</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Standard Deviation, U/L</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>4.5</td></tr><tr><td rowspan=1 colspan=1>Coefficient of Variation</td><td rowspan=1 colspan=1>4.6%</td><td rowspan=1 colspan=1>4.8%</td><td rowspan=1 colspan=1>4.6%</td><td rowspan=1 colspan=1>8.1%</td></tr></table>

Point of Care Laboratory: ACE Lipase Reagent

Point of care precision evaluations were determined following CLSI EP10-A3. Three serum based samples containing varying levels of lipase were tested on the ACE Axcel Clinical Chemistry System analyzer in one run per day with three replicates of each level per run for 5 days.

<table><tr><td rowspan=1 colspan=3>Lipase</td><td rowspan=1 colspan=2>Within Run</td><td rowspan=1 colspan=2>Total</td></tr><tr><td rowspan=1 colspan=1>Lab</td><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Meanμg/dL</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>POL 1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>39.13</td><td rowspan=1 colspan=1>1.97</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>2.70</td><td rowspan=1 colspan=1>6.9</td></tr><tr><td rowspan=1 colspan=1>POL 2</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>33.96</td><td rowspan=1 colspan=1>2.49</td><td rowspan=1 colspan=1>7.3</td><td rowspan=1 colspan=1>2.49</td><td rowspan=1 colspan=1>7.3</td></tr><tr><td rowspan=1 colspan=1>POL 3</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>33.20</td><td rowspan=1 colspan=1>2.14</td><td rowspan=1 colspan=1>6.4</td><td rowspan=1 colspan=1>2.14</td><td rowspan=1 colspan=1>6.4</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>POL 1</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>257.75</td><td rowspan=1 colspan=1>3.56</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>6.14</td><td rowspan=1 colspan=1>2.4</td></tr><tr><td rowspan=1 colspan=1>POL 2</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>267.93</td><td rowspan=1 colspan=1>5.31</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>9.62</td><td rowspan=1 colspan=1>3.6</td></tr><tr><td rowspan=1 colspan=1>POL 3</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>261.65</td><td rowspan=1 colspan=1>3.85</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>6.64</td><td rowspan=1 colspan=1>2.5</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>POL 1</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>416.27</td><td rowspan=1 colspan=1>4.96</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>7.89</td><td rowspan=1 colspan=1>1.9</td></tr><tr><td rowspan=1 colspan=1>POL 2</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>432.68</td><td rowspan=1 colspan=1>5.97</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>11.97</td><td rowspan=1 colspan=1>2.8</td></tr><tr><td rowspan=1 colspan=1>POL 3</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>426.92</td><td rowspan=1 colspan=1>3.14</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>9.73</td><td rowspan=1 colspan=1>2.3</td></tr></table>

# b. Linearity/assay reportable range:

ACE Direct Total Iron-Binding capacity (TIBC) Reagent   
Linearity studies were carried out using dilutions of a spiked serum samples. Twelve concentrations were prepared by mixing spiked serum samples in known portions of saline. All samples were measured in triplicate. The sample range tested was 29.7 to $7 4 2 \mu \mathrm { g / d L }$ .

<table><tr><td rowspan=1 colspan=1>Claimed Measuring Range</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>r2}$</td></tr><tr><td rowspan=1 colspan=1>42-700 μg/dL</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>1.016</td><td rowspan=1 colspan=1>0.9966</td></tr></table>

Based on the linearity data, the measuring range claimed from $4 2 { \cdot } 7 0 0 ~ \mu \mathrm { g / d L }$ was supported.

# ACE Serum Iron Reagent

Linearity studies were carried out using dilutions of a spiked serum samples. Ten concentrations were prepared by mixing spiked serum samples in known portions of saline. All samples were measured in triplicate. The sample range tested was 11.7 to $6 0 6 . 0 \mu \mathrm { g / d L }$ .

<table><tr><td rowspan=1 colspan=1>Claimed Measuring Range</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>r{$</td></tr><tr><td rowspan=1 colspan=1>12-600μg/dL</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0.990</td><td rowspan=1 colspan=1>0.9996</td></tr></table>

Based on the linearity data, the measuring range claimed from $1 2 { \cdot } 6 0 0 { \mu } \mathrm { g } / \mathrm { d L }$ was supported.

# ACE Lipase Reagent

Linearity studies were carried out using dilutions of a spiked serum samples.   
Thirteen samples with increasing lipase concentrations were measured in triplicate.   
The sample range tested was 14.5 to $7 5 7 . 7 \mathrm { U / L }$ .

<table><tr><td rowspan=1 colspan=1>Claimed Measuring Range</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>r}$</td></tr><tr><td rowspan=1 colspan=1>15-700 U/L</td><td rowspan=1 colspan=1>0.294</td><td rowspan=1 colspan=1>1.000</td><td rowspan=1 colspan=1>1.000</td></tr></table>

Based on the linearity data, the measuring range claimed from $1 5 { \mathrm { - } } 7 0 0 \ \mathrm { U / L }$ was supported.

c. Traceability, Stability, Expected values (controls, calibrators, or methods): Traceability ACE Direct Total Iron-Binding capacity (TIBC) Reagent Traceable to another commercially available FDA cleared assay by method comparison. The calibrator was previously cleared under k060264.

ACE Serum Iron Reagent Traceable to NIST SRM 937. The calibrator was previously cleared under k961588.

# ACE Lipase Reagent

Traceable to another commercially available FDA cleared assay by method comparison. The calibrator was previously cleared under k897150.

d. Detection limit:

Detection Limits (LoB and LoD) were performed using 60 blank and 60 low serum samples as per the recommendations of CLSI EP 17A protocol. LoB and LoD were calculated to be: TIBC: $\mathrm { L o B } = 3 5 ~ \mu \mathrm { g / d L }$ , $\mathrm { L o D } = 4 2 ~ \mu \mathrm { g / d L }$ ; Total Iron: $\mathrm { L o B } = 2 ~ \mu \mathrm { g / d L }$ , $\mathrm { L o D } = 5 ~ \mu \mathrm { g } / \mathrm { d L }$ ; Lipase: $\mathrm { L o B } = 8 . 4 4 \mathrm { U } / \mathrm { L }$ , $\mathrm { L o D } = 1 0 . 6 3 \mathrm { U } / \mathrm { L }$ .

e. Analytical specificity:

ACE Direct Total Iron-Binding capacity (TIBC) Reagent

Interference studies were performed by using serum pools containing $2 5 8 . 0 ~ \mu \mathrm { g / d L }$ to $2 9 6 . 6 \mu \mathrm { g / d L }$ and $6 0 0 ~ \mu \varrho / \mathrm { d L }$ of TIBC with individual interferents at a range of concentrations. The sera were assayed for TIBC ( $\mathrm { \acute { n } } = 3$ replicates) and the mean result calculated. Interference was considered to be significant by the sponsor if the analyte recovery changed by $> \pm 1 0 \%$ . The results reported were obtained on ACE Axcel Clinical Chemistry System analyzer using fresh ACE Direct Total Iron-Binding capacity (TIBC) Reagent.

Interferents Claim   

<table><tr><td rowspan=1 colspan=1>Interferents</td><td rowspan=1 colspan=1>No Significant Interference At or Below</td></tr><tr><td rowspan=1 colspan=1>Unconjugated Bilirubin</td><td rowspan=1 colspan=1>55 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Hemolysis</td><td rowspan=1 colspan=1>250 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Lipemia (Intralipid)</td><td rowspan=1 colspan=1>1000 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>3 mg/dL</td></tr></table>

# ACE Serum Iron Reagent

Interference studies were performed by using two serum pools containing ${ 7 0 \mu \ g / \mathrm { d L } }$ and $2 2 0 \mu \ g / \mathrm { d L }$ with individual interferents at a range of concentrations. The sera were assayed for Iron $\mathrm { \acute { n } } = 3$ replicates) and the mean result calculated. Interference was considered to be significant by the sponsor if the analyte recovery changed by more than $\pm 1 0 \%$ . The results reported were obtained on ACE Axcel Clinical Chemistry System analyzer using fresh ACE Serum Iron Reagent.

Interferents Claim   

<table><tr><td rowspan=1 colspan=1>Interferents</td><td rowspan=1 colspan=1>No Significant Interference At or Below</td></tr><tr><td rowspan=1 colspan=1>Unconjugated Bilirubin</td><td rowspan=1 colspan=1>56 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Hemolysis</td><td rowspan=1 colspan=1>62.5 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>500 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>6 mg/dL</td></tr></table>

# ACE Lipase Reagent

Interference studies were performed by using two serum pools containing ${ 4 0 } \mathrm { U / L }$ and $3 8 0 \mathrm { U / L }$ lipase with individual interferents at a range of concentrations. The sera were assayed for lipase $\mathbf { \tilde { n } } = 3$ replicates) and the mean result calculated. Interference was considered to be significant by the sponsor if the analyte recovery changed by more than the least detectable $0 \mathrm { r } > 1 0 \%$ . The results reported were obtained on ACE Axcel Clinical Chemistry System analyzer using fresh ACE Lipase Reagent.

Interferents Claim   

<table><tr><td rowspan=1 colspan=1>Interferents</td><td rowspan=1 colspan=1>No Significant Interference At or Below</td></tr><tr><td rowspan=1 colspan=1>Unconjugated Bilirubin</td><td rowspan=1 colspan=1>8 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Hemolysis</td><td rowspan=1 colspan=1>1000 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Triglycerides</td><td rowspan=1 colspan=1>693 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>6 mg/dL</td></tr></table>

Because hemolysis interferes with the above assays, therefore, the sponsor put the following limitations in the labeling for TIBC and Iron:

“Do not use hemolyzed sample.”

f. Assay cut-off: Not applicable

2. Comparison studies:

a. Method comparison with predicate device:

Studies were carried out according to CLSI EP09-A2-IR.

In house: ACE Direct Total Iron-Binding capacity (TIBC) Reagent ACE Clinical Chemistry System, ACE TIBC Reagent (k931786) was used as the predicate method, using recommended applications and procedures on the ACE Clinical Chemistry System analyzer and calibrating with ACE Direct TIBC Calibrators. One hundred and nine serum samples were assayed in parallel by both the candidate and predicate methods and the results compared by Deming regression. The range tested was 96 to $5 9 8 ~ \mu \mathrm { g / d L }$ . Two samples were altered.

The comparison by Deming regression resulted in a slope of 0.979 $( 9 5 \% C \mathrm { I } = 0 . 9 6 1$ to 0.9998), an intercept of 2.5 $9 5 \% C \mathrm { I } = - 9 . 2$ to 4.3), correlation coefficient of ${ \tt R } 2 =$ 0.9950, and a std. error of 9.1.

Point of Care Laboratory: ACE Direct Total Iron-Binding capacity (TIBC) Reagent ACE Clinical Chemistry System, ACE Serum Iron Reagent (k931786) was used as the predicate method, using recommended applications and procedures on the ACE Clinical Chemistry System analyzer and calibrating with ACE Serum Iron Calibrators. Results compared by Deming regression. Twenty five samples were altered.

<table><tr><td rowspan=1 colspan=1>POL</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>Rangeμg/dL</td><td rowspan=1 colspan=1>RegressionEquation</td><td rowspan=1 colspan=1>CorrelationCoefficient</td><td rowspan=1 colspan=1>StandardError</td><td rowspan=1 colspan=1>ConfidenceIntervalSlope</td><td rowspan=1 colspan=1>ConfidenceIntervalIntercept</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>55</td><td rowspan=1 colspan=1>59-659</td><td rowspan=1 colspan=1>y = 0.982x+4.2</td><td rowspan=1 colspan=1>0.9987</td><td rowspan=1 colspan=1>6.2</td><td rowspan=1 colspan=1>0.968 to0.996</td><td rowspan=1 colspan=1>-0.8 to 9.3</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>46</td><td rowspan=1 colspan=1>53 -621</td><td rowspan=1 colspan=1>y = 0.978x+9.2</td><td rowspan=1 colspan=1>0.9980</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>0.960 to0.997</td><td rowspan=1 colspan=1>3.1 to 15.2</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>45</td><td rowspan=1 colspan=1>135 -615</td><td rowspan=1 colspan=1>y = 0.964x+5.6</td><td rowspan=1 colspan=1>0.9902</td><td rowspan=1 colspan=1>11.2</td><td rowspan=1 colspan=1>9.923 to1.006</td><td rowspan=1 colspan=1>-8.2 to 19.4</td></tr></table>

# In house: ACE Serum Iron Reagent

ACE Serum Iron Reagent was used as the predicate method, using recommended applications and procedures on the ACE Clinical Chemistry System analyzer and calibrating with ACE Serum Iron Calibrators. One hundred thirty serum samples were assayed in parallel by both the candidate and predicate methods and the results compared by Deming regression. The range tested was 13 to $5 5 0 ~ \mu \mathrm { g / d L }$ . Nine samples were altered.

The comparison by Deming regression resulted in a slope of 1.006 $( 9 5 \% C \mathrm { I } = 1 . 0 0 0$ to 1.012), an intercept of 1.8 $9 5 \% C \mathrm { I } = - 2 . 7$ to -1.0), correlation coefficient of ${ \tt R } 2 =$ 0.9995, and a std. error of 3.3.

# Point of Care Laboratory: ACE Serum Iron Reagent

ACE Clinical Chemistry System, ACE Serum Iron Reagent (k931786) was used as the predicate method, using recommended applications and procedures on the ACE Clinical Chemistry System analyzer and calibrating with ACE Serum Iron Calibrators. Results compared by Deming regression. Thirty two samples were altered.

<table><tr><td rowspan=1 colspan=1>POL</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>Rangeμg/dL</td><td rowspan=1 colspan=1>RegressionEquation</td><td rowspan=1 colspan=1>CorrelationCoefficient</td><td rowspan=1 colspan=1>StandardError</td><td rowspan=1 colspan=1>ConfidenceIntervalSlope</td><td rowspan=1 colspan=1>ConfidenceIntervalIntercept</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>63</td><td rowspan=1 colspan=1>31-578</td><td rowspan=1 colspan=1>y = 1.002x- 1.8</td><td rowspan=1 colspan=1>0.9998</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>0.997 to1.007</td><td rowspan=1 colspan=1>-2.7 to -0.6</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>54</td><td rowspan=1 colspan=1>12 -548</td><td rowspan=1 colspan=1>y = 1.007x+2.0</td><td rowspan=1 colspan=1>0.9993</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>0.997 to1.017</td><td rowspan=1 colspan=1>0.1 to 3.9</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>33 -575</td><td rowspan=1 colspan=1>y = 1.028x+7.2</td><td rowspan=1 colspan=1>0.9992</td><td rowspan=1 colspan=1>4.6</td><td rowspan=1 colspan=1>1.016 to1.041</td><td rowspan=1 colspan=1>5.3 to 9.2</td></tr></table>

# In house: ACE Lipase Reagent

ACE Lipase Reagent was used as the predicate method, using recommended applications and procedures on the ACE Clinical Chemistry System analyzer and calibrating with ACE Lipase Calibrators. One hundred eleven serum samples were assayed in parallel by both the test and predicate methods and the results compared by Deming regression. The range tested was 15.6 to $6 9 7 . 5 \mathrm { U } / \mathrm { L }$ . Four samples were altered.

The comparison by Deming regression resulted in a slope of 0.982 $( 9 5 \% C \mathrm { I } = 0 . 9 7 0$ to 0.994), an intercept of 3.97 $\mathrm { 9 5 \% C I } = 1 . 9 7$ to 5.97), correlation coefficient of ${ \tt R } 2 =$ 0.9980, and a std. error of 9.06.

# Point of Care Laboratory: ACE Lipase Reagent

ACE Clinical Chemistry System, ACE Lipase Reagent (k931786) was used as the predicate method, using recommended applications and procedures on the ACE Clinical Chemistry System analyzer and calibrating with ACE Lipase Calibrators. Results compared by Deming regression. Sixteen samples were altered.

<table><tr><td rowspan=1 colspan=1>POL</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>RangeU/L</td><td rowspan=1 colspan=1>RegressionEquation</td><td rowspan=1 colspan=1>CorrelationCoefficient</td><td rowspan=1 colspan=1>StandardError</td><td rowspan=1 colspan=1>ConfidenceIntervalSlope</td><td rowspan=1 colspan=1>ConfidenceIntervalIntercept</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>15.9-664.7</td><td rowspan=1 colspan=1>y = 1.013x+1.89</td><td rowspan=1 colspan=1>0.9997</td><td rowspan=1 colspan=1>4.44</td><td rowspan=1 colspan=1>1.006 to1.020</td><td rowspan=1 colspan=1>0.36 to3.41</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>52</td><td rowspan=1 colspan=1>15.1 -674.3</td><td rowspan=1 colspan=1>y = 1.013x+ 1.98</td><td rowspan=1 colspan=1>0.9993</td><td rowspan=1 colspan=1>7.89</td><td rowspan=1 colspan=1>1.002 to1.023</td><td rowspan=1 colspan=1>-4.74 to0.79</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>45</td><td rowspan=1 colspan=1>16.1 -684.2</td><td rowspan=1 colspan=1>y = 1.038x+ 1.22</td><td rowspan=1 colspan=1>0.9996</td><td rowspan=1 colspan=1>4.64</td><td rowspan=1 colspan=1>1.030 to1.047</td><td rowspan=1 colspan=1>-2.89 to0.44</td></tr></table>

b. Matrix comparison: Not Applicable.

3. Clinical studies:

a. Clinical Sensitivity: Not Applicable.   
b. Clinical specificity: Not Applicable.   
c. Other clinical supportive data (when a. and $b$ . are not applicable):

4. Clinical cut-off: Not Applicable.

5. Expected values/Reference range: TIBC expected values are $2 5 0 { - } 4 5 0 \mu \mathrm { g } / \mathrm { d L } ^ { 1 }$ .

Total Iron expected values are: Male $6 5 { \mathrm { - } } 1 7 5 \mu \mathrm { g / d L }$ and female $5 0 { \mathrm { - } } 1 7 0 \mu \mathrm { g } / \mathrm { d L } ^ { \mathrm { ~ 1 ~ } }$ 1 .

Lipase Reagent expected values are: 21 – 67 International Units $\left( \mathrm { U } / \mathrm { L } \right)$ at $3 7 ^ { \circ } \mathrm { C } ^ { 1 }$

1. Tietz, N. W. (Ed.), Clinical Guide to Laboratory Tests, $3 ^ { \mathrm { r d } }$ Edition, W.B. Saunders Co., Philadelphia, PA (2005).

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.